Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study.

MLA

Llibre, Josep M., et al. “Long-Term Effectiveness of Unboosted Atazanavir plus Abacavir/Lamivudine in Subjects with Virological Suppression: A Prospective Cohort Study.” Medicine, vol. 95, no. 40, Oct. 2016, p. e5020. EBSCOhost, https://doi.org/10.1097/MD.0000000000005020.

APA

Llibre, J. M., Cozzi-Lepri, A., Pedersen, C., Ristola, M., Losso, M., Mocroft, A., Mitsura, V., Falconer, K., Maltez, F., Beniowski, M., Vullo, V., Hassoun, G., Kuzovatova, E., Szlavik, J., Kuznetsova, A., Stellbrink, H.-J., Duvivier, C., Edwards, S., Laut, K., & Paredes, R. (2016). Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study. Medicine, 95(40), e5020. https://doi.org/10.1097/MD.0000000000005020

Chicago

Llibre, Josep M, Alessandro Cozzi-Lepri, Court Pedersen, Matti Ristola, Marcelo Losso, Amanda Mocroft, Viktar Mitsura, et al. 2016. “Long-Term Effectiveness of Unboosted Atazanavir plus Abacavir/Lamivudine in Subjects with Virological Suppression: A Prospective Cohort Study.” Medicine 95 (40): e5020. doi:10.1097/MD.0000000000005020.